Orders from 3030 CZK Free delivery from 6315 CZK Ready for pickup dead drop: collect in 5 min Free parcel delivery from 6315 CZK

Substances · Arylcyclohexylamines

3-HO-PCP

C17H25NO CAS 79787-43-2 Analytical reference material — not for human consumption
Preferred name
3-HO-PCP
IUPAC name
3-(1-piperidin-1-ylcyclohexyl)phenol
Parent CAS number (reference)
79787-43-2
Molecular formula
C17H25NO
Molecular weight
259.4 g/mol
InChIKey
AMSXTZUCNOKUEN-UHFFFAOYSA-N
PubChem
CID 133277
Source
PubChem
Verified synonyms & catalog abbreviations
3-Hydroxyphencyclidine 3HOPCP 3-HO PCP

Matching Listings in This Store's Catalog

Verified Neurochemical & Toxicological Intelligence

3-HO-PCP

Ultra-Potent NMDA Antagonist with mu-Opioid Affinity Arylcyclohexylamine
Verified PubChem & CAS Identity C17H25NO · CAS 79787-43-2 / 79295-51-5 · CID 133277
Calibrated Physical Form Pure Crystalline / Analytical Powder (≥98%)
≥98% Analytical Purity Verified 259.4 g/mol
Peer-Reviewed & Agency Citations 2 · verified sources

Receptor Telemetry & Mechanism of Action

NMDA Uncompetitive Channel Blockade Primary
SERT / DAT Monoamine Reuptake Tone Low

High-affinity NMDA blocker (Ki = 30 nM) uniquely displaying measurable mu-opioid receptor affinity in rodent assays alongside calm, non-manic sedation.

Biotransformation & Active Metabolites

Phase II glucuronidation of the 3-phenolic hydroxyl.

Temporal Pharmacokinetics

Ultra-Potent NMDA Antagonist with mu-Opioid Affinity — Most potent arylcyclohexylamine by weight (active at 2–7 mg) and warmer/calmer than 3-MeO-PCP, with heightened respiratory depression hazard if mixed with depressants.

  1. Onset 30–75 min
  2. Peak Window 1.5–3 h
  3. Total Window 4–6 h
  4. Residual / Half-Life 4–10 h residual

Most potent arylcyclohexylamine by weight (active at 2–7 mg) and warmer/calmer than 3-MeO-PCP, with heightened respiratory depression hazard if mixed with depressants.

Quantitative Response Spectrum (Published Literature)

Third-person observational & toxicological brackets reported in scientific and harm-reduction literature — reference telemetry only, never consumption advice.

Threshold
1–2 mg
Cognitive & Sensory

Subtle threshold receptor activity (Ultra-Potent NMDA Antagonist with mu-Opioid Affinity).

Somatic & Autonomic

Minimal baseline autonomic shift.

Light
2–4 mg
Cognitive & Sensory

Mild, clear-headed expression of primary class profile.

Somatic & Autonomic

Light somatic modulation.

Common Reference
4–7 mg
Cognitive & Sensory

Full characteristic neurochemical and perceptual profile documented in literature.

Somatic & Autonomic

Moderate somatic relaxation, ataxia, or autonomic tone depending on class.

Strong
7–10 mg
Cognitive & Sensory

Pronounced intensity, cognitive/motor impairment, or deep immersion.

Somatic & Autonomic

Marked somatic load and heightened adverse-event sensitivity.

Heavy / Toxic Zone
12+ mg
Cognitive & Sensory

Amnesia, blackout, acute dysphoria, confusion, or anesthetic dissociation.

Somatic & Autonomic

High toxicity zone: severe motor loss, cardiovascular strain, or respiratory hazard.

Interaction Matrix & Critical Contraindications

Critical Hazard — Never Combine

Alcohol, Opioids (O-DSMT), Benzodiazepines, and GHB/GBL

Severe ataxia, unconsciousness, respiratory depression, and fatal vomiting aspiration.

Elevated Hazard — Avoid

Strong Stimulants (Cathinones, Cocaine, Amphetamines)

Compounds hypertension, tachycardia, manic disorientation, and psychotic episodes.

Caution / Receptor Attenuation

Cannabis & Psychedelics

Dramatically intensifies dissociation, confusion, and sensory immersion.

Structural Isomer & Sibling Comparison

Most potent arylcyclohexylamine by weight (active at 2–7 mg) and warmer/calmer than 3-MeO-PCP, with heightened respiratory depression hazard if mixed with depressants.

Physicochemical Stability & Storage

Physical Form: White to off-white crystalline powder or fine crystals. · Soluble in water, ethanol, and saline.

Chemically stable when kept dry, sealed, and protected from light at room temperature.

Cross-Tolerance & Dependence Profile

Slowly decaying NMDA cross-tolerance shared across all arylcyclohexylamines (halves in ~3–7 days, full baseline 2+ weeks). Chronic frequent exposure carries documented urological/bladder epithelial toxicity.

Spot-test and isomer verification

Spot-test notes for 3-HO-PCP. Morris shifts grey-blue to slate-blue, not the lilac-purple of ketamine HCl. The free phenolic OH also reacts purple-violet with Marquis and Mecke.

Spot tests and routine EI-MS cannot separate ring regioisomers, especially 3-FXE (CID 137332183) from the ortho isomer 2F-NENDCK (CAS 2850352-64-4); differentiation requires ATR-FTIR (700–900 cm⁻¹ ring-substitution bands) or ¹⁹F-NMR and ¹H-NMR.

Codes on this card

Short meanings for the abbreviations printed with this substance.

Open the full glossary →
DAT Dopamine transporter

DAT is the protein that collects dopamine back from the gap between nerve cells. A card that names DAT is quoting a laboratory result about that protein.

SERT Serotonin transporter

SERT is the protein that collects serotonin back into the nerve cell. A higher number than at DAT means the serotonin transporter needed more concentration to reach the halfway point.

NMDA NMDA glutamate channel

NMDA is a glutamate receptor that works like a gated channel. Ketamine-type and PCP-type cards cite it when papers describe that channel as blocked.

μ Mu opioid receptor

Mu, written μ, is the opioid receptor subtype that opioid papers treat as the main one. O-DSMT cards cite it, and the same cards warn about breathing when depressant classes are combined.

EC₅₀ / IC₅₀ Halfway concentration

EC50 is the concentration where a lab saw half of the maximum measured effect. IC50 is the concentration where it saw half of the maximum block. Smaller means that halfway point came at a lower concentration.

Kᵢ Binding tightness in nanomoles

Ki says how tightly a compound sits on a receptor in a binding test. It is written in nanomoles per litre. A Ki of 1 nM means very tight binding in that experiment.

OUN / Oddech Synergistic CNS & Respiratory Depression

Combining two central nervous system depressants (such as benzodiazepines, alcohol, GHB, or opioids) multiplies sedation and can suppress brainstem breathing drive.

Tolerancja × Cross-Tolerance

When exposure to one compound reduces sensitivity to other compounds that act on the same receptor family (for example across all 5-HT2A lysergamides or all GABA-A modulators).

Comprehensive Analytical & Toxicological Monograph

3-HO-PCP (3-(1-piperidin-1-ylcyclohexyl)phenol; CAS 79787-43-2, PubChem CID 133277) is a arylcyclohexylamine reference compound (C17H25NO, 259.4 g/mol) classified pharmacologically as a Ultra-Potent NMDA Antagonist with mu-Opioid Affinity. High-affinity NMDA blocker (Ki = 30 nM) uniquely displaying measurable mu-opioid receptor affinity in rodent assays alongside calm, non-manic sedation. Phase II glucuronidation of the 3-phenolic hydroxyl. In published observational and toxicological literature, threshold response is noted at 1–2 mg, light range at 2–4 mg, common reference range at 4–7 mg, strong intensity at 7–10 mg, and heavy/adverse territory at 12+ mg, with an onset of 30–75 min, peak window of 1.5–3 h, and total duration of 4–6 h (4–10 h residual). Most potent arylcyclohexylamine by weight (active at 2–7 mg) and warmer/calmer than 3-MeO-PCP, with heightened respiratory depression hazard if mixed with depressants. Critical contraindications include Alcohol, Opioids (O-DSMT), Benzodiazepines, and GHB/GBL.

Chemical Architecture & Structural Profile

3-HO-PCP (3-(1-piperidin-1-ylcyclohexyl)phenol) is a reference compound belonging to the Arylcyclohexylamines class, characterized by the molecular formula C17H25NO and a molar mass of 259.4 g/mol. The parent molecule is indexed under CAS registry number 79787-43-2 and in the NCBI PubChem database as CID 133277 (Standard InChIKey: AMSXTZUCNOKUEN-UHFFFAOYSA-N). This molecule shares its empirical formula (C17H25NO) with positional or structural isomers; unambiguous analytical identification requires matching the full IUPAC structure, CAS number (79787-43-2), and spectroscopic profile.

Citations

Reference Toxicology & Safety Profile

In documented chemical and harm-reduction literature (PubChem / PsychonautWiki, CC BY 4.0), 3-HO-PCP is indexed within the Arylcyclohexylamines structural group. Toxicological notes (PsychonautWiki): toxic threshold is unknown. Dependence liability (PsychonautWiki): moderately addictive with a high potential for adverse side effects such as psychosis. Documented cross-tolerance class: dissociative. Standard laboratory handling precautions—including nitrile gloves, eye protection, and local exhaust ventilation—apply whenever handling the reference material.

Citations

Analytical Use & Laboratory Notice

This reference sheet provides chemical, analytical, and toxicological provenance only. The material is strictly not for human consumption, diagnostic, or veterinary use. Research-use labelling does not establish legal status in any jurisdiction.

Citations

Documented Contraindications & Interactions

High-risk / Dangerous combinations